glp-1 reta Retatrutide: Comprehensive Safety and Clinical Data Retatrutide Triple Agonist (GLP-1/GIP/GCG) |
Description
Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment
with a GLP-1
At Genesis Lifestyle Medicine, weve helped many people use GLP-1 medications to improve their health and mobility
The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field
